Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 May-Jun;44(3):431-8.
doi: 10.1134/s0026893310030118.

[Liver cirrhosis patogenetics: polymorphism of glutation S-transferase genes]

[Article in Russian]
Comparative Study

[Liver cirrhosis patogenetics: polymorphism of glutation S-transferase genes]

[Article in Russian]
I A Goncharova et al. Mol Biol (Mosk). 2010 May-Jun.

Abstract

Association of deletion polymorphism in GSTT1 and GSTM1 genes and polymorphic variant A313G of GSTP1 gene with cirrhosis diseases and 4-year survival rate for the Tomsk region (West Siberia) patients were tested. Homozygous deletion of GSTM1 gene (null genotype) was a protective factor for alcoholic and mixed (HCV, HBV and alcohol) liver cirrhosis development. The patients from the joint group (all etiology forms) as well as having alcoholic and mixed cirrhosis had lower frequency of GSTM1 null genotype (39.2, 39.0, and 34.2%, respectively) in comparison with the control group (64.6%). The GSTM1 null genotype and GSTP1 gene A313G polymorphic variant correlated with the patients' survival rate. The patients survived in comparison with the dead had higher frequency of a GSTM1 null genotype (46.6 vs. 30.2%) and GSTP1 AA genotype (63.1 vs. 40.5%), and lower frequency of GSTP1 AG (A313G) genotype (31.1 vs. 51.2%). A survival rate was 2.5 times higher for patients having GSTP1 AA genotype in comparison with the GG and AG genotype carriers and 2 times higher for patients having GSTM1 null genotype than the gene carriers. A 4-year fatal case probability was 2.3 times higher among the patients having heterozygous AG GSTP1 genotype in comparison with homozygous AA and GG genotype carriers.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 1993 Dec 9;329(24):1777-82 - PubMed
    1. Chem Biol Drug Des. 2007 Jun;69(6):429-34 - PubMed
    1. Clin Infect Dis. 2005 Sep 1;41(5):676-80 - PubMed
    1. J Biol Chem. 2006 Jun 30;281(26):18193-200 - PubMed
    1. Vopr Virusol. 1999 Nov-Dec;44(6):247-9 - PubMed

Substances